
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
J. Morganroth
₹20,022

18
by J. Morganroth, E. Neil Moore
Springer Nature · 2011
Free delivery. Nothing extra to pay at checkout.
Available Offers
The Evaluation of Beat Blocker and Calcium Antagonist Drugs: 18 by J. Morganroth & E.